SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is actively discussing a significant and rapid decline in the value of the recently launched meme coin, with many traders labeling the event a "rug pull" and expressing skepticism over its legitimacy. Opinions are highly polarized, ranging from ridicule of those who invested to cynical comparisons with other politically themed tokens.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as investors weigh the company's strong post-earnings growth against a newly disclosed pre-arranged trading plan by Chairman Larry Ellison to potentially sell up to 50 million shares. While some traders express concern over the potential supply overhang and the stock's recent volatility, others characterize the sell-off as an overreaction, pointing to robust AI-driven backlog growth and institutional interest as bullish indicators.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

GoldCoin is trending as traders speculate on its potential for price appreciation, with some community members drawing comparisons to historical market movements and early-stage crypto assets. Discussion remains fragmented, characterized by a mix of speculative enthusiasm for its growth potential and questions about its underlying utility.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The community is debating the impact of Treasury yield fluctuations and persistent inflation, with many traders expressing skepticism toward Treasury Secretary Scott Bessent's bond buyback efforts. Investors are primarily focused on whether rising yields and Middle East tensions will force a Federal Reserve rate hike or lead to a market downturn.

Ethena

Ethena (ENA) is trending due to excitement surrounding its fee-switch vote, which establishes a framework for future token buybacks funded by protocol revenue once USDe circulating supply milestones are reached. While sentiment is largely bullish based on the token's institutional infrastructure, partnerships, and potential for a rally alongside broader crypto market momentum, some traders express caution, highlighting that buybacks are not immediate and the asset has recently faced selling pressure.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco is trending as traders analyze the stock's consolidation phase and recent volatility, with sentiment largely driven by expectations for long-term growth in the nuclear energy sector and its role as a key supplier for the nuclear fuel cycle. While some market participants express frustration over price movement and suggest a cooling period for nuclear-related equities, many maintain a bullish outlook on the company's fundamentals and strategic positioning amidst global energy security concerns.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is receiving attention following its listing on Robinhood and ongoing discussions surrounding its post-quantum cryptography roadmap. The community remains divided, with some traders expressing optimism about institutional integration and technical upgrades, while others remain skeptical, citing historical price declines and the foundation's selling activity.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is trending following a strong quarterly earnings report that exceeded estimates for both revenue and EPS, accompanied by an increased share buyback program and resilient consumer spending metrics. Investors are also monitoring the company's expanding partnerships in AI-driven commerce and stablecoin settlement initiatives, which serve as key growth catalysts.

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Novartis AG - ADR

Novartis AG

Novartis is currently facing significant market pressure following the failure of two late-stage clinical trials within one week, leading to a substantial decline in share price. Investors are expressing concern over the company's recent acquisition strategy, specifically the high-value purchase of Avidity Biosciences, and calls for a board overhaul have emerged.

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

Arbitrum is receiving attention as traders debate its long-term potential, frequently citing its role in the Robinhood chain and growing stablecoin activity as catalysts for it being undervalued. While many express frustration with the token's recent price performance and unlock schedule, others remain bullish on its fundamentals as a leading Ethereum Layer 2 solution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sellas Life Sciences (SLS) shares declined significantly amid community speculation regarding a third-party clinical trial survival model and concerns over a prolonged quiet period. While traders debated the potential for a trial failure versus a delayed event rate signaling therapeutic efficacy, institutional ownership levels remain a focal point of contention among investors.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS PR Newswire NEW YORK, Sept. 10, 2026 NEW YORK, Sept. 10...

Dow, S&P 500, Nasdaq Futures Edge Higher Ahead Of PPI, Jobless Claims: NVDA, AAPL, META, ORCL, TSM, TSLA, SLS In Focus 

Equity

Retail sentiment on Stocktwits turned cautious, dipping to ‘neutral’ on SPY and ‘bearish’ on QQQ.

SLS, IBRX In Focus: Canadian Insurance Giant Manulife’s Unit Raises Stakes Ahead Of Key Cancer Catalysts 

Its IBRX stake jumped 27.5% to 243,678 shares worth $2.13 million, bringing both positions’ combined value to $2.86 million.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS PR Newswire NEW YORK, Sept. 3, 2026 NEW YORK, Sept. 3, 2026...

Sellas Gears Up To Present Preclinical SLS009 Data For Pancreatic Cancer At Major Oncology Conference

Three abstracts evaluating SLS009 have been accepted for poster presentations at the AACR Conference on Pancreatic Cancer later in September.

Nasdaq, Dow, S&P 500 Futures Begin September On Weak Footing: Why NVDA, AAPL, TSLA, PANW, DELL, SLS, HUT Are In Focus

Retail sentiment on Stocktwits remained constructive despite rising geopolitical friction: ‘bullish’ on SPY and ‘neutral’ on QQQ.


SLS, IBRX Stocks Post August Gains: Eli Lilly’s Latest $2.9B Deal Has Retail Traders Bracing For An ‘M&A Rampage’

Retail traders viewed the Merida acquisition as evidence that Big Pharma will pay rich premiums for immune-focused platforms.

Sellas CEO Stergiou Says ‘Rigorous, Unblinded’ Data From Pivotal AML Trial Will 'Speak For Itself' As REGAL Catalyst Nears

In a post on LinkedIn on Monday, Angelos Stergiou said despite speculation and outside commentary ‘naturally’ increasing, the company will let the data speak for itself.


Why Are Nasdaq, S&P 500 Futures Subdued Premarket? NVDA, AAPL, INTC, CRWD, RKLB, SLS Stocks In Focus

Retail sentiment on Stocktwits remained constructive despite rising geopolitical friction: ‘bullish’ on SPY and ‘neutral’ on QQQ.



Frank Gerola's BMF Targets SELLAS Life Sciences $3 Billion Valuation: Biotech's 'Most Expensive Coin Flip'

Short seller BMF Capital disclosed a short position in SELLAS Life Sciences, arguing the market has 'dangerously overvalued' the biotech.read more...

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Bearish Sentiment

$TMDX

$SLS

Which of these trending stocks are you most tempted to buy - $ON, $TMDX, $SLS, or $BE?

Feed

News

Sentiment

Earnings

Fundamentals

Info

SLS SELLAS Life Sciences Group Inc

Fundamentals

Latest SLS News